Table 7.
Functional characterization of H19 in other system tumors.
| Tumor types | Expression | Role | Function role | miRNAs | Related genes | References |
|---|---|---|---|---|---|---|
| Lymphoma | upregulation | oncogene | proliferation | / | AKT | 158 |
| Myeloma | upregulation | oncogene | proliferation and apoptosis | miR-152-3p | BRD4 | 161 |
| Myeloma | upregulation | oncogene | proliferation, migration, viability, cell cycle, and apoptosis | miR-29b-3p | MCL-1 | 8 |
| Myeloma | upregulation | oncogene | chemotherapeutic sensitivity | / | AKT | 162 |
| Melanoma | upregulation | oncogene | glucose metabolism and growth | miR-106a-5p | E2F3 | 9 |
| Melanoma | upregulation | oncogene | proliferation, migration, and invasion | / | NF‑κB | 165 |
| Melanoma | upregulation | oncogene | chemotherapeutic sensitivity | miR-18b | IGF | 22 |
| Leukemia | upregulation | oncogene | proliferation | miR-19a/b | ID2 | 167 |
| Leukemia | upregulation | oncogene | proliferation and apoptosis | / | ID2 | 168 |
| Leukemia | upregulation | oncogene | proliferation and apoptosis | miR-29a-3p | Wnt/β-Catenin | 169 |
| Osteosarcoma | / | oncogene | migration and invasion | miR-200s | ZEB1/ZEB2 | 171 |
| Osteosarcoma | upregulation | oncogene | migration and invasion | / | NF‑κB | 172 |